✦ LIBER ✦

PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple Sclerosis

✍ Scribed by Silva, N.L.; Takemoto, M.L.S.; Cruz, R.B.; Suzuki, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND35 Belgian Cost-Utility Analysis of G

✍ S. Drieskens; K. Moeremans 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND64 Cost-Minimization Analysis of IFNB

✍ F. Pan; J. Goh; C. Wang; M. Meinhardt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND33 Cost Minimization Analysis of Fing

✍ B. Verheggen; M. Treur; M. Groot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND21 ESTIMATED COSTS OF FINGOLIMOD MONI

✍ Trautman, H.; Clark, J.; Huleatt, H. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND18 Cost- Effectiveness of Fingolimod

✍ I.F. Soria-Cedillo; V. Baca-Muro; L. García-Conde; E. Lemus-Carmona 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB